Daniel Cohen, Ph.D., is the CEO and Co-founder of 3DBio Therapeutics. Prior to 3DBio, Daniel was an Engagement Manager at McKinsey & Company in New York, where he focused on manufacturing, industrials, healthcare, and 3D printing. He received his Ph.D., as well as B.S. and M.S. degrees, in Mechanical Engineering from Cornell University, with minors in Biomedical and Electrical Engineering. Dr. Cohen was awarded both the National Science Foundation Graduate Research Fellowship, and the Department of Homeland Security Graduate Fellowship. At Cornell, he focused on bioprinting technology, completing his doctoral dissertation on 3D printing & bioprinting and holds numerous publications and patents in the field.